Alzheimer's disease, oestrogen and mitochondria: An ambiguous relationship

Molecular Neurobiology

Volumn 46, Issue 1, 2012, Pages 151-160

  Grimm, Amandine ^a,b   Lim, Yun An ^c   Mensah Nyagan, Ayikoe Guy ^b   Götz, Jürgen ^c   Eckert, Anne ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

ABAD; Alzheimer's disease; Mitochondria; Neurosteroids; Oestrogen

Indexed keywords

ALCOHOL DEHYDROGENASE; AMYLOID BETA BINDING AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ENZYME ACTIVITY; ESTROGEN ACTIVITY; ESTROGEN SYNTHESIS; HUMAN; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

EID: 84868115047     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8281-x     Document Type: Article

References (75)

1. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu EE (1981) Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 78(8):4704-4707 (Pubitemid 12225548)
2. Mensah-Nyagan AG, Do-Rego JL, Beaujean D, Luu-The V, Pelletier G, Vaudry H (1999) Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol Rev 51(1):63-81 (Pubitemid 29113866)
3. Patte-Mensah C, Kibaly C, Boudard D, Schaeffer V, Begle A, Saredi S, Meyer L, Mensah-Nyagan AG (2006) Neurogenic pain and steroid synthesis in the spinal cord. J Mol Neurosci 28(1):17-31. doi:10.1385/JMN:30:3:341 (Pubitemid 46568352)
4. Plassart-Schiess E, Baulieu EE (2001) Neurosteroids: recent findings. Brain Res Rev 37(1-3):133-140 (Pubitemid 34020727)
5. TsutsuiK(2008) Neurosteroids in the Purkinje cell: biosynthesis,mode of action and functional significance. MolNeurobiol 37(2-3):116-125. doi:10.1007/s12035-008-8024-1
6. Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJ, Garcia-Segura LM, Lambert JJ, Mayo W, Melcangi RC, Parducz A, Suter U, Carelli C, Baulieu EE, Akwa Y (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71(1):3-29 (Pubitemid 37377932)
7. Mensah-Nyagan AG, Kibaly C, Schaeffer V, Venard C, Meyer L, Patte-Mensah C (2008) Endogenous steroid production in the spinal cord and potential involvement in neuropathic pain modulation. J Steroid Biochem Mol Biol 109(3-5):286-293. doi:10.1016/j.jsbmb.2008.03.002 (Pubitemid 351711685)
8. Foryst-Ludwig A, Kintscher U (2010) Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 122(1-3):74-81. doi:10.1016/j.jsbmb.2010.06.012
9. Arnold S, Beyer C (2009) Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. J Neurochem 110(1):1-11. doi:10.1111/j.1471-4159.2009.06133.x
10. Barron AM, Pike CJ (2012) Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed) 4:976-997
11. Pike CJ, Carroll JC, Rosario ER, Barron AM (2009) Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 30(2):239-258. doi:10.1016/j.yfrne.2009.04.015
12. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3(3):186-191. doi:10.1016/j.jalz.2007.04.381 (Pubitemid 46825511)
13. Eckert A, Schmitt K, Gotz J (2011) Mitochondrial dysfunction-The beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-beta toxicity. Alzheimers Res Ther 3(2):15. doi:10.1186/alzrt74
14. Hy LX, Keller DM (2000) Prevalence of AD among whites: A summary by levels of severity. Neurology 55(2):198-204 (Pubitemid 30604618)
15. Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24-28. doi:10.1196/annals.1297 (Pubitemid 38951278)
16. Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62(6):685-691. doi:10.1001/archpsyc.62.6.685 (Pubitemid 40973444)
17. Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ (2011) Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging 32 (4):604-613. doi:10.1016/j.neurobiolaging.2009.04. 008
18. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ (2007) Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27(48):13357-13365. doi:10.1523/JNEUROSCI.2718- 07.2007 (Pubitemid 350220504)
19. CallahanMJ, LipinskiWJ, Bian F, Durham RA, Pack A,Walker LC (2001) Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol 158(3):1173-1177 (Pubitemid 32221809)
20. Wang J, Tanila H, Puolivali J, Kadish I, van Groen T (2003) Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol Dis 14 (3):318-327 (Pubitemid 37543511)
21. Sturchler-Pierrat C, Staufenbiel M (2000) Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model. Ann N Y Acad Sci 920:134-139 (Pubitemid 32056562)
22. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216:92-103. doi:10.1016/j.brainres.2008. 03.079
23. Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L (2010) Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice. Neurobiol Dis 37(2):294-306. doi:10.1016/j.nbd.2009.09.004
24. Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293(5534):1491-1495. doi:10.1126/science (Pubitemid 32807681)
25. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293(5534):1487-1491. doi:10.1126/science.1058189 (Pubitemid 32801551)
26. Schuessel K, Leutner S, Cairns NJ, Muller WE, Eckert A (2004) Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J Neural Transm 111(9):1167-1182. doi:10.1007/s00702-004-0156-5 (Pubitemid 39222776)
27. Vina J, Lloret A (2010) Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloidbeta peptide. J Alzheimers Dis 20(Suppl 2):S527-533. doi:10.3233/JAD-2010-100501
28. Schaeffer V, Patte-Mensah C, Eckert A,Mensah-Nyagan AG (2006) Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins. J Neurobiol 66(8):868-881. doi:10.1002/neu.20267 (Pubitemid 44025539)
29. Schaeffer V, Patte-Mensah C, Eckert A, Mensah-Nyagan AG (2008) Selective regulation of neurosteroid biosynthesis in human neuroblastoma cells under hydrogen peroxide-induced oxidative stress condition. Neuroscience 151(3):758-770. doi:10.1016/j.neuroscience.2007.11.032
30. Olivieri G, Novakovic M, Savaskan E, Meier F, Baysang G, Brockhaus M, Muller-Spahn F (2002) The effects of betaestradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion. Neuroscience 113(4):849-855 (Pubitemid 35245254)
31. Schaeffer V, Meyer L, Patte-Mensah C, Eckert A, Mensah-Nyagan AG (2008) Dose-dependent and sequence-sensitive effects of amyloid-beta peptide on neurosteroidogenesis in human neuroblastoma cells. Neurochem Int 52(6):948-955. doi:10.1016/j.neuint.2008.01.010
32. Brown RC, Cascio C, Papadopoulos V (2000) Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and betaamyloid peptide. J Neurochem 74(2):847-859 (Pubitemid 30053759)
33. Brown RC, Han Z, Cascio C, Papadopoulos V (2003) Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology. Neurobiol Aging 24(1):57-65 (Pubitemid 36001985)
34. Griffin LD, Gong W, Verot L, Mellon SH (2004) Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med 10(7):704-711. doi:10.1038/nm1073 (Pubitemid 38937635)
35. Smith CD, Wekstein DR, Markesbery WR, Frye CA (2006) 3alpha, 5alpha-THP: A potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia. Psychopharmacology (Berl) 186(3):481-485. doi:10.1007/s00213-005-0186-1 (Pubitemid 43800848)
36. Castellani RJ, Rolston RK, Smith MA (2010) Alzheimer disease. Dis Mon 56(9):484-546. doi:10.1016/j.disamonth.2010.06.001
37. Amtul Z, Wang L, Westaway D, Rozmahel RF (2010) Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience 169(2):781-786. doi:10.1016/j.neuroscience.2010.05.031
38. Frye CA, Walf AA (2008) Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice. Neurobiol Learn Mem 89(1):17-26. doi:10.1016/j.nlm.2007.09.008 (Pubitemid 350102253)
39. Goodenough S, Schleusner D, Pietrzik C, Skutella T, Behl C (2005) Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience 132 (3):581-589. doi:10.1016/j.neuroscience. 2004.12.029
40. Chen S, Wang JM, Irwin RW, Yao J, Liu L, Brinton RD (2011) Allopregnanolone promotes regeneration and reduces betaamyloid burden in a preclinical model of Alzheimer's disease. PLoS One 6(8):e24293. doi:10.1371/journal.pone.0024293
41. Simpkins JW, Yi KD, Yang SH, Dykens JA (2010) Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta 1800(10):1113-1120. doi:10.1016/j.bbagen.2009.11.013
42. Nilsen J (2008) Estradiol and neurodegenerative oxidative stress. Front Neuroendocrinol 29(4):463-475. doi:10.1016/j.yfrne.2007.12.005
43. Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV, Vina J (2003) Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 34(5):546-552 (Pubitemid 36254828)
44. Brinton RD (2008) Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. Adv Drug Deliv Rev 60(13-14):1504-1511. doi:10.1016/j.addr.2008.06.003
45. Scheffler IE (2001) A century of mitochondrial research: achievements and perspectives. Mitochondrion 1(1):3-31 (Pubitemid 33586018)
46. Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60(5):748-766. doi:10.1016/j.neuron.2008.10. 010
47. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB, Muller-Spahn F, Haass C, Czech C, Pradier L, Muller WE, Eckert A (2004) Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 279(48):50310-50320. doi:10.1074/jbc.M405600200 (Pubitemid 39577847)
48. Leuner K, Schutt T, Kurz C, Eckert SH, Schiller C, Occhipinti A, Mai S, Jendrach M, Eckert GP, Kruse SE, Palmiter RD, Brandt U, Drose S, Wittig I, Willem M, Haass C, Reichert AS, Muller WE (2012) Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal 16 (12):1421-1433. doi:10.1089/ars.2011.4173
49. Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Gotz J, Eckert A (2011) Insights into mitochondrial dysfunction: aging amyloid-beta and tau-A deleterious trio. Antioxid Redox Signal. doi:10.1089/ars.2011.4400
50. Rone MB, Fan J, Papadopoulos V (2009) Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim Biophys Acta 1791(7):646-658. doi:10.1016/j.bbalip.2009.03.001
51. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX (2006) Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138(3):749-756. doi:10.1016/j.neuroscience. 2005.05.063
52. Borras C, Gambini J, Lopez-Grueso R, Pallardo FV, Vina J (2010) Direct antioxidant and protective effect of estradiol on isolated mitochondria. Biochim Biophys Acta 1802(1):205-211. doi:10.1016/j.bbadis.2009.09.007
53. Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RD, Nilsen J (2008) Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 149(6):3167-3175. doi:10.1210/en.2007-1227 (Pubitemid 351724522)
54. Simpkins JW, Dykens JA (2008) Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev 57(2):421-430. doi:10.1016/j.brainresrev.2007.04. 007 (Pubitemid 351381759)
55. Yan SD, Fu J, Soto C, Chen X, Zhu H, Al-Mohanna F, Collison K, Zhu A, Stern E, Saido T, Tohyama M, Ogawa S, Roher A, Stern D (1997) An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389 (6652):689-695. doi:10.1038/39522 (Pubitemid 27458947)
56. Yang SY, He XY, Schulz H (2005) Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. Trends Endocrinol Metab 16(4):167-175. doi:10.1016/j.tem.2005.03.006 (Pubitemid 40603096)
57. Yan SD, Stern DM (2005) Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Int J Exp Pathol 86(3):161-171. doi:10.1111/j.0959-9673.2005.00427.x (Pubitemid 40813912)
58. Kristofikova Z, Bockova M, Hegnerova K, Bartos A, Klaschka J, Ricny J, Ripova D, Homola J (2009) Enhanced levels of mitochondrial enzyme 17beta-hydroxysteroid dehydrogenase type 10 in patients with Alzheimer disease and multiple sclerosis. Mol Biosyst 5(10):1174-1179. doi:10.1039/b904799a
59. Seo JS, Lee KW, Kim TK, Baek IS, Im JY, Han PL (2011) Behavioral stress causes mitochondrial dysfunction via ABAD up-regulation and aggravates plaque pathology in the brain of a mouse model of Alzheimer disease. Free Radic Biol Med 50 (11):1526-1535. doi:10.1016/j.freeradbiomed.2011.02.035
60. Yao J, Irwin R, Chen S, Hamilton R, Cadenas E, Brinton RD (2011) Ovarian hormone loss induces bioenergetic deficits and mitochondrial beta-amyloid. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2011.03.001
61. Lim YA, Grimm A, Giese M, Mensah-Nyagan AG, Villafranca JE, ttner LM, Eckert A, Gotz J (2011) Inhibition of the mitochondrial enzyme ABAD restores the amyloid-beta-mediated deregulation of estradiol. PLoS One 6(12):e28887. doi:10.1371/journal.pone.0028887
62. Kissinger CR, Rejto PA, Pelletier LA, Thomson JA, Showalter RE, AbreoMA, Agree CS, Margosiak S,Meng JJ, Aust RM, Vanderpool D, Li B, Tempczyk-Russell A,Villafranca JE (2004) Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics. J Mol Biol 342(3):943-952. doi:10.1016/j.jmb.2004.07 (Pubitemid 39165660)
63. Holzmann J, Rossmanith W (2009) tRNA recognition, processing, and disease: hypotheses around an unorthodox type of RNase P in human mitochondria. Mitochondrion 9(4):284-288. doi:10.1016/j.mito.2009.03.008
64. Paganini-Hill A, Henderson VW (1996) Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 156 (19):2213-2217 (Pubitemid 26361914)
65. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (9025):429-432. doi:10.1016/S0140-6736(96) 03356-9 (Pubitemid 26267873)
66. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291(14):1701-1712. doi:10.1001/jama.291.14. 1701 (Pubitemid 38489892)
67. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3):321-333 (Pubitemid 34761611)
68. Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 66(5):1836-1844 (Pubitemid 26118770)
69. Nilsen J, Brinton RD (2002) Impact of progestins on estrogeninduced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 143(1):205-212 (Pubitemid 34056421)
70. Penning TM, Sharp RB, Krieger NR (1985) Purification and properties of 3 alpha-hydroxysteroid dehydrogenase from rat brain cytosol. Inhibition by nonsteroidal anti-inflammatory drugs and progestins. J Biol Chem 260(28):15266-15272 (Pubitemid 16147972)
71. Henderson VW, Brinton RD (2010) Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog Brain Res 182:77-96. doi:10.1016/S0079-6123(10)82003-5
72. Gibbs RB (2010) Estrogen therapy and cognition: A review of the cholinergic hypothesis. Endocr Rev 31(2):224-253. doi:10.1210/er.2009-0036
73. Hogervorst E, Bandelow S (2010) Sex steroids to maintain cognitive function in women after the menopause: A meta-analyses of treatment trials. Maturitas 66(1):56-71. doi:10.1016/j.maturitas.2010.02.005
74. Mittal G, Carswell H, Brett R, Currie S, Kumar MN (2011) Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology. J Control Release 150(2):220-228. doi:10.1016/j.jconrel.2010.11.013
75. Grant WB (1999) Dietary links to Alzheimer's disease: 1999 update. J Alzheimers Dis 1(4-5):197-201